Prothena | PRTA - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Akebia Therapeutics USD 173.88M 10.95M 2026-03
ALKERMES USD 662.09M 62.59M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 24.96B 534M 2026-03
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Immunic USD 38.36M 7.74M 2026-03
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
MacroGenics USD 95.94M 52.82M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Prothena USD 32.52M 8.33M 2026-03
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03